91
TITLE: Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological Systems
AUTHORS: Souto, EB ; Dias-Ferreira, João ; Craveiro, SA; Severino, P; Sanchez Lopez, E; Garcia, ML; Silva, AM; Souto, SB; Mahant, S;
PUBLISHED: 2019, SOURCE: PATHOGENS, VOLUME: 8, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 24 Handle
IN MY: ORCID
92
TITLE: Development and Optimization of Alpha-Pinene-Loaded Solid Lipid Nanoparticles (SLN) Using Experimental Factorial Design and Dispersion Analysis  Full Text
AUTHORS: Aleksandra Zielinska; Nuno R Ferreira; Alessandra Durazzo; Massimo Lucarini; Nicola Cicero; Soukaina El Mamouni; Amelia M Silva; Izabela Nowak; Antonello Santini; Eliana B Souto ;
PUBLISHED: 2019, SOURCE: MOLECULES, VOLUME: 24, ISSUE: 15
INDEXED IN: Scopus WOS
IN MY: ORCID
94
TITLE: In Vitro Cytotoxicity of Oleanolic/Ursolic Acids-Loaded in PLGA Nanoparticles in Different Cell Lines  Full Text
AUTHORS: Silva, AM; Alvarado, HL; Abrego, G; Martins Gomes, C; Garduno Ramirez, ML; Garcia, ML; Calpena, AC; Souto, EB ;
PUBLISHED: 2019, SOURCE: PHARMACEUTICS, VOLUME: 11, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 42
IN MY: ORCID
95
TITLE: Key production parameters for the development of solid lipid nanoparticles by high shear homogenization  Full Text
AUTHORS: Souto, EB ; Doktorova, S; Zielinska, A; Silva, AM;
PUBLISHED: 2019, SOURCE: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, VOLUME: 24, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 29
IN MY: ORCID
96
TITLE: Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II
AUTHORS: Vieira, R; Souto, SB; Sanchez Lopez, E; Machado, AL; Severino, P; Jose, S; Santini, A; Silva, AM; Fortuna, A; Garcia, ML; Souto, EB ;
PUBLISHED: 2019, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 8, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 36 Handle
IN MY: ORCID
97
TITLE: Meglumine-based supra-amphiphile self-assembled in water as a skin drug delivery system: Influence of unfrozen bound water in the system bioadhesiveness  Full Text
AUTHORS: de Souza, ALR; Fonseca, M; Ferreira, LMB; Kurokawa, SSS; Kiill, CP; Ferreira, NN; Pyrrho, AD; Sarmento, VHV; Silva, AM; Gremiao, MPD; Ribeiro, CA;
PUBLISHED: 2019, SOURCE: COLLOIDS AND SURFACES B-BIOINTERFACES, VOLUME: 184
INDEXED IN: Scopus WOS CrossRef: 3
IN MY: ORCID
98
TITLE: Myasthenia gravis: State of the art and new therapeutic strategies
AUTHORS: Souto, EB ; Lima, B; Campos, JR; Martins Gomes, C; Souto, SB; Silva, AM;
PUBLISHED: 2019, SOURCE: JOURNAL OF NEUROIMMUNOLOGY, VOLUME: 337
INDEXED IN: Scopus WOS CrossRef: 9 Handle
IN MY: ORCID
99
TITLE: Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I
AUTHORS: Vieira, R; Souto, SB; Sanchez Lopez, E; Machado, AL; Severino, P; Jose, S; Santini, A; Fortuna, A; Garcia, ML; Silva, AM; Souto, EB ;
PUBLISHED: 2019, SOURCE: PHARMACEUTICALS, VOLUME: 12, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 52 Handle
IN MY: ORCID
100
TITLE: Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines  Full Text
AUTHORS: Silva, AM; Martins Gomes, C; Fangueiro, JF; Andreani, T ; Souto, EB ;
PUBLISHED: 2019, SOURCE: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, VOLUME: 24, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 40
IN MY: ORCID
Page 10 of 24. Total results: 234.